These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 19089921)
81. Lysyl Oxidase Is Predictive of Unfavorable Outcomes and Essential for Regulation of Vascular Endothelial Growth Factor in Hepatocellular Carcinoma. Zhu J; Huang S; Wu G; Huang C; Li X; Chen Z; Zhao L; Zhao Y Dig Dis Sci; 2015 Oct; 60(10):3019-31. PubMed ID: 26048020 [TBL] [Abstract][Full Text] [Related]
82. 15-lipoxygenase metabolites of docosahexaenoic acid inhibit prostate cancer cell proliferation and survival. O'Flaherty JT; Hu Y; Wooten RE; Horita DA; Samuel MP; Thomas MJ; Sun H; Edwards IJ PLoS One; 2012; 7(9):e45480. PubMed ID: 23029040 [TBL] [Abstract][Full Text] [Related]
83. MMAC/PTEN tumor suppressor gene regulates vascular endothelial growth factor-mediated angiogenesis in prostate cancer. Koul D; Shen R; Garyali A; Ke LD; Liu TJ; Yung WK Int J Oncol; 2002 Sep; 21(3):469-75. PubMed ID: 12168088 [TBL] [Abstract][Full Text] [Related]
84. Dual inhibition of COX-2/5-LOX blocks colon cancer proliferation, migration and invasion in vitro. Che XH; Chen CL; Ye XL; Weng GB; Guo XZ; Yu WY; Tao J; Chen YC; Chen X Oncol Rep; 2016 Mar; 35(3):1680-8. PubMed ID: 26707712 [TBL] [Abstract][Full Text] [Related]
85. Anti-vascular endothelial growth factor receptor 2 antibody reduces tumorigenicity and metastasis in orthotopic prostate cancer xenografts via induction of endothelial cell apoptosis and reduction of endothelial cell matrix metalloproteinase type 9 production. Sweeney P; Karashima T; Kim SJ; Kedar D; Mian B; Huang S; Baker C; Fan Z; Hicklin DJ; Pettaway CA; Dinney CP Clin Cancer Res; 2002 Aug; 8(8):2714-24. PubMed ID: 12171905 [TBL] [Abstract][Full Text] [Related]
86. Mechanistic contribution of ubiquitous 15-lipoxygenase-1 expression loss in cancer cells to terminal cell differentiation evasion. Moussalli MJ; Wu Y; Zuo X; Yang XL; Wistuba II; Raso MG; Morris JS; Bowser JL; Minna JD; Lotan R; Shureiqi I Cancer Prev Res (Phila); 2011 Dec; 4(12):1961-72. PubMed ID: 21881028 [TBL] [Abstract][Full Text] [Related]
87. 15-lipoxygenase-1 production is lost in pancreatic cancer and overexpression of the gene inhibits tumor cell growth. Hennig R; Kehl T; Noor S; Ding XZ; Rao SM; Bergmann F; Fürstenberger G; Büchler MW; Friess H; Krieg P; Adrian TE Neoplasia; 2007 Nov; 9(11):917-26. PubMed ID: 18030360 [TBL] [Abstract][Full Text] [Related]
88. 15-Lipoxygenase-1 as a tumor suppressor gene in colon cancer: is the verdict in? Il Lee S; Zuo X; Shureiqi I Cancer Metastasis Rev; 2011 Dec; 30(3-4):481-91. PubMed ID: 22037943 [TBL] [Abstract][Full Text] [Related]
89. MKK4 suppresses metastatic colonization by multiple highly metastatic prostate cancer cell lines through a transient impairment in cell cycle progression. Szmulewitz RZ; Clark R; Lotan T; Otto K; Taylor Veneris J; Macleod K; Rinker-Schaeffer C Int J Cancer; 2012 Feb; 130(3):509-20. PubMed ID: 21351092 [TBL] [Abstract][Full Text] [Related]
90. Reduction of isoforms of 15-lipoxygenase (15-LOX)-1 and 15-LOX-2 in human breast cancer. Jiang WG; Watkins G; Douglas-Jones A; Mansel RE Prostaglandins Leukot Essent Fatty Acids; 2006 Apr; 74(4):235-45. PubMed ID: 16556493 [TBL] [Abstract][Full Text] [Related]
91. Tumor-suppressing 15-lipoxygenase-2: time for prime time? Guo Y; Nie D Cell Cycle; 2014; 13(12):1836-7. PubMed ID: 24865420 [No Abstract] [Full Text] [Related]
92. Arachidonate 12-lipoxygenase may serve as a potential marker and therapeutic target for prostate cancer stem cells. Yin B; Yang Y; Zhao Z; Zeng Y; Mooney SM; Li M; Xu X; Song Y; Wu B; Yang Z Int J Oncol; 2011 Apr; 38(4):1041-6. PubMed ID: 21225230 [TBL] [Abstract][Full Text] [Related]
93. 12-HETER1/GPR31, a high-affinity 12(S)-hydroxyeicosatetraenoic acid receptor, is significantly up-regulated in prostate cancer and plays a critical role in prostate cancer progression. Honn KV; Guo Y; Cai Y; Lee MJ; Dyson G; Zhang W; Tucker SC FASEB J; 2016 Jun; 30(6):2360-9. PubMed ID: 26965684 [TBL] [Abstract][Full Text] [Related]
94. OXER1, a G protein-coupled oxoeicosatetraenoid receptor, mediates the survival-promoting effects of arachidonate 5-lipoxygenase in prostate cancer cells. Sarveswaran S; Ghosh J Cancer Lett; 2013 Aug; 336(1):185-95. PubMed ID: 23643940 [TBL] [Abstract][Full Text] [Related]
95. Therapeutic Molecular Targetingof 15-Lipoxygenase-1 in Colon Cancer. Wu Y; Fang B; Yang XQ; Wang L; Chen D; Krasnykh V; Carter BZ; Morris JS; Shureiqi I Mol Ther; 2008 May; 16(5):886-892. PubMed ID: 28178489 [TBL] [Abstract][Full Text] [Related]
96. Fatty acids and their lipid mediators in the induction of cellular apoptosis in cancer cells. Biswas P; Datta C; Rathi P; Bhattacharjee A Prostaglandins Other Lipid Mediat; 2022 Jun; 160():106637. PubMed ID: 35341977 [TBL] [Abstract][Full Text] [Related]
97. A dormant state modulated by osmotic pressure controls clonogenicity of prostate cancer cells. Havard M; Dautry F; Tchénio T J Biol Chem; 2011 Dec; 286(51):44177-44186. PubMed ID: 22039055 [TBL] [Abstract][Full Text] [Related]
98. Qualitative and Quantitative analysis of 3D predicted arachidonate 15-lipoxygenase-B (15-LOX-2) from Homo sapiens. Arora N; Singh VK; Shah K; Pandey-Rai S Bioinformation; 2012; 8(12):555-61. PubMed ID: 22829730 [TBL] [Abstract][Full Text] [Related]
99. Dormancy in solid tumors: implications for prostate cancer. Ruppender NS; Morrissey C; Lange PH; Vessella RL Cancer Metastasis Rev; 2013 Dec; 32(3-4):501-9. PubMed ID: 23612741 [TBL] [Abstract][Full Text] [Related]
100. Lipoxygenases at the Intersection of Infection and Carcinogenesis. Amoah AS; Pestov NB; Korneenko TV; Prokhorenko IA; Kurakin GF; Barlev NA Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612771 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]